Patent details
300703
Product Name:
Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300703
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1713823
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300703
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/14/924/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
16/05/2014
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
12/11/2014
First Marketing Authorization date:
16/05/2014
Grant date:
20/07/2017
Activation date:
28/01/2025
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
09/11/2015
SPC/SPC Extension Expiration Date:
15/05/2029
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
12/11/2014
Name:
Medivir AB
Address:
Blasieholmsgatan 2, 141 22, 11148 Stockholm, Sweden (SE)
Agent
Name:
ir. F.A. Geurts c.s.
From:
12/11/2014
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
36/20
Publication date:
02/09/2020
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
30/17
Publication date:
26/07/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
46/15
Publication date:
11/11/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2014/48
Publication date:
26/11/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/01/2025
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
20/07/2017
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/0/7/0/0/0400300703/docs/300703_7_outgoingcorrespondence20170724101535481.pdf
20/07/2017
SPC Documents
Certificate SPC
1
PDF
/3/0/7/0/0/0400300703/docs/300703_9_supplprotectioncertificate20170724101535534.pdf
04/12/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/0/7/0/0/0400300703/docs/300703_1_outgoingcorrespondence20141204.pdf
17/11/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/0/7/0/0/0400300703/docs/300703_6_outgoingcorrespondence20141117.pdf
12/11/2014
Application Form
First filed application form
3
PDF
/3/0/7/0/0/0400300703/docs/300703_0_applicationform20141112.pdf
12/11/2014
SPC Documents
Marketing Authorization SPC
3
PDF
/3/0/7/0/0/0400300703/docs/300703_2_supplprotectioncertificate20201021042322560.pdf
12/11/2014
SPC Documents
Annex SPC
1
PDF
/3/0/7/0/0/0400300703/docs/300703_3_supplprotectioncertificate20201021043441854.pdf
12/11/2014
SPC Documents
Annex SPC
2
PDF
/3/0/7/0/0/0400300703/docs/300703_4_supplprotectioncertificate20201021042008631.pdf
12/11/2014
SPC Documents
Summary of the characteristics of the product
39
PDF
/3/0/7/0/0/0400300703/docs/300703_5_supplprotectioncertificate20201021042811296.pdf
12/11/2014
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/3/0/7/0/0/0400300703/docs/300703_8_incomingcorrespondencepaper20141112.pdf